Clinical Trial: Drug Combination on Exercise Performance at High Altitude

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional

Official Title: Enhancing Physical Performance and Mitigating Acute Mountain Sickness Via Pharmaceutical Intervention While at Altitude

Brief Summary: This study is being conducted to determine the effectiveness of using two FDA approved medications in concert to reduce the likelihood of sickness due to low oxygen levels and to reduce the decrement in physical performance at higher elevations. The investigators hypothesize that this drug combination will reduce the symptoms of acute mountain sickness and improve exercise performance at high altitude compared to placebo.

Detailed Summary:
Sponsor: University of Montana

Current Primary Outcome: Time (Minutes) to Complete 2 Miles on a Treadmill [ Time Frame: after arriving at high altitude (within 1 hour) ]

Original Primary Outcome: physical performance [ Time Frame: upon arrival to high altitude ]

Current Secondary Outcome:

Original Secondary Outcome: physical performance [ Time Frame: 24 hours after primary outcome measure ]

Information By: University of Montana

Dates:
Date Received: July 11, 2013
Date Started: August 2013
Date Completion:
Last Updated: January 28, 2016
Last Verified: January 2016